VirtualScopics, Inc. (VSCP) Announces Record Level of New Contracts
VirtualScopics, Inc. (VSCP), the country's forefront leader and developer of image-based biomarker solutions for the pharmaceutical, biotechnology and medical industries, announced that the company's year to date contracted agreements total $8.4 million. This significant increase does not even include an additional $4.6 million in awarded agreements still awaiting signature. Specifically, these agreements include clients from the top 15 pharmaceutical, biotechnology and medical device companies. VirtualScopics has signed 47 new contracts, with 39 additional contracts still awaiting signature and final approval. Furthermore, of the newly signed and awarded contracts, 24% are Phase III studies, 65% are Phase I/II studies and 11%…